Published
An older peptide COA is a record to evaluate, not an automatic pass or failure. Check what sample it covered, when testing occurred, how that sample connects to the relevant lot and what evidence addresses the material’s subsequent storage.
Report age, authenticity and current inventory matching are separate questions. A recent-looking date cannot replace the missing relationship between a sample and stock.
How old is too old for a peptide COA?
A calendar cutoff alone cannot answer that for every material and situation. First identify what each date means: manufacture, sample submission, laboratory analysis, receipt, publication or the date a web page was edited. These dates can describe different events.
A seller updating a page does not, by itself, mean the sample was tested again. Conversely, an older report does not prove that the record is false. Review the actual document and the applicable evidence rather than treating a page’s “updated” label as a new analytical finding.
Also distinguish document-header information from laboratory findings. Janoshik explains that sample and batch information in its report header can be supplied by the client. Those fields help identify a submission; an inventory connection still needs to be demonstrated. Janoshik: report-header details.
What if the report predates the batch currently being offered?
Consider this fictional training timeline, which does not describe a Peptide Serum lot or laboratory report:
| Event | Information supplied | Reading decision |
|---|---|---|
| January: sample analyzed | Report names material X and lot ALPHA | The findings concern that submitted sample |
| March: new stock listed | Listing names material X and lot BETA | The material name matches; the lot relationship does not |
| July: listing edited | No new test or ALPHA-to-BETA record supplied | The edit does not resolve the missing connection |
The supported conclusion is limited: a report exists for sample ALPHA, while its relationship to the offered BETA stock is unresolved in the supplied information. Do not rewrite that as “all current stock passed.” Also do not claim that BETA failed a test that the record never reports.
Does an authentic COA establish that the material stayed unchanged?
Authenticity answers whether the report matches its issuer’s record. It does not automatically reconstruct later handling or establish a supported storage interval. FDA’s stability discussion explains that drug-product expiration dating depends on appropriate data and stated storage conditions. That principle is useful context; it does not turn a research-material COA into a drug approval or stability program. FDA: expiration dating and stability testing.
Keep the analytical findings and the later storage question in separate fields. When information is absent, record it as unavailable rather than assigning a shelf life from the age of the PDF.
What should I ask the supplier about an older COA?
- Which exact material, formulation, sample and lot does this report identify?
- Which date is the analytical date, and which dates describe other events?
- What records connect the analyzed sample to the stock currently being offered?
- What storage conditions and interval are supported for that material?
- Has additional testing been performed, and which original record reports its actual findings?
A useful request is specific: “Please identify the report for this product and lot, explain the sample-to-stock connection, and provide the applicable storage or later-testing documentation on file.” It does not presume that a new certificate must exist or that a missing field proves misconduct.
For Peptide Serum records, use Lab Testing. Match the exact entry, such as BPC-157 5 mg or BPC-157 10 mg, rather than transferring a report between labeled amounts. The COA review worksheet provides a place to retain the gaps and follow-up questions.
Sources checked October 21, 2026. The timeline is illustrative; it is not a finding about any supplier’s testing.